Press releases
- Nevro to Present at BofA Securities 2024 Healthcare Conference
- Nevro Reports First-Quarter 2024 Financial Results
- Nevro to Report First-Quarter 2024 Financial Results and Host Earnings Conference Call on May 7, 2024
- Nevro Receives FDA 510(k) Clearance to Use SI Fixation System Without Need to Include Lateral Screw
Key statistics
As of last trade Nevro Corp (1N7:FRA) traded at 9.00, 0.00% above its 52-week low of 9.00, set on May 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 9.00 |
---|---|
High | 9.00 |
Low | 9.00 |
Bid | 8.80 |
Offer | 8.85 |
Previous close | 9.10 |
Average volume | 11.11 |
---|---|
Shares outstanding | 36.73m |
Free float | 35.47m |
P/E (TTM) | -- |
Market cap | 360.31m USD |
EPS (TTM) | -2.28 USD |
Data delayed at least 15 minutes, as of May 23 2024 07:00 BST.
More ▼